Oncotelic Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 29 Jun 23 | BuyUS$8,925 | Vuong Trieu | Individual | 425,000 | US$0.021 | |
| 28 Jun 23 | BuyUS$1,950 | Vuong Trieu | Individual | 75,000 | US$0.026 | |
| 16 Jun 23 | BuyUS$2,600 | Vuong Trieu | Individual | 100,000 | US$0.026 | |
| 14 Jun 23 | BuyUS$13,040 | Vuong Trieu | Individual | 400,000 | US$0.033 | |
| 26 May 23 | BuyUS$4,327 | Vuong Trieu | Individual | 126,888 | US$0.034 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 20,111,031 | 5.03% |
| General Public | 180,543,044 | 45.2% |
| Individual Insiders | 199,029,783 | 49.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 98,916,747 | US$4.0m | 0% | no data | |||
| 41,630,811 | US$1.7m | 0% | no data | |||
| 23,455,990 | US$937.1k | 0% | no data | |||
| 17,073,604 | US$682.1k | 0% | no data | |||
| 16,780,384 | US$670.4k | 0% | no data | |||
| 16,456,480 | US$657.4k | 0% | no data | |||
| 3,330,647 | US$133.1k | 0% | no data | |||
| 1,137,314 | US$45.4k | 0% | no data | |||
| 358,837 | US$14.3k | 0% | no data |